Table 1 Patient clinical baseline characteristics
Total N = 37 | Non-relapsed / refractory patients N = 30 | Relapsed/refractory patients N = 7 | P value | |
|---|---|---|---|---|
Male / n (%) | 9 (24.3%) | 8 (26.7%) | 1 (14.3%) | 0.652 |
Age / year, median (range) | 61 (33–84) | 61 (33–84) | 57 (47–83) | 0.885 |
Pathological subtype | ||||
DLBCL / n | 26 | 20 | 6 | 0.161 |
FL / n | 2 | 1 | 1 | |
MALT / n | 9 | 9 | 0 | |
IPI low-risk / n (%) | 20 (54.1%) | 18 (60.0%) | 2 (28.6%) | 0.212 |
Presence of trachea compression symptom / n (%) | 22(59.5%) | 18 (60.0%) | 4 (57.1%) | 1.000 |
Presence of Hashimoto’s thyroiditis / n (%) | 19 (51.4%) | 14 (46.7%) | 5 (71.4%) | 0.405 |
Elevated LDH / n (%) | 22 (59.5%) | 18 (60.0%) | 4 (57.1%) | 1.000 |
Ki67 index>30% / n (%) | 29 (78.4%) | 22 (73.3%) | 7 (100%) | 0.308 |
Follow-up / month, median (range) | 25 (8-180) | 25 (8-151) | 37 (8-180) | 0.690 |